He WT - Search Results

1

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Li C, Zhang LM, Zhang X, Huang X, Liu Y, Li MQ, Xing S, Yang T, Xie L, Jiang FC, Jiang HY, He WT, Zhou P. Li C, et al. Among authors: he wt. Transplantation. 2017 Feb;101(2):284-293. doi: 10.1097/TP.0000000000001471. Transplantation. 2017. PMID: 27607533

2

Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice.

He W, Fang Z, Wang F, Wu K, Xu Y, Zhou H, Du D, Gao Y, Zhang WN, Niki T, Hirashima M, Yuan J, Chen ZK. He W, et al. Transplantation. 2009 Sep 27;88(6):782-90. doi: 10.1097/TP.0b013e3181b47f25. Transplantation. 2009. PMID: 19920777

3

Porcine hepatocyte isolation and reversible immortalization mediated by retroviral transfer and site-specific recombination.

Meng FY, Chen ZS, Han M, Hu XP, He XX, Liu Y, He WT, Huang W, Guo H, Zhou P. Meng FY, et al. Among authors: he xx, he wt. World J Gastroenterol. 2010 Apr 7;16(13):1660-4. doi: 10.3748/wjg.v16.i13.1660. World J Gastroenterol. 2010. PMID: 20355246 Free PMC article.

4

Galectin-9 in combination with rapamycin induces cardiac allograft tolerance in mice.

Cai L, Zhou H, Fang Z, Yuan J, Niki T, Hirashima M, He W, Chen ZK. Cai L, et al. Transplantation. 2013 Aug 27;96(4):379-86. doi: 10.1097/TP.0b013e31829b07b5. Transplantation. 2013. PMID: 23838998

5

TIGIT negatively regulates inflammation by altering macrophage phenotype.

Chen X, Lu PH, Liu L, Fang ZM, Duan W, Liu ZL, Wang CY, Zhou P, Yu XF, He WT. Chen X, et al. Among authors: he wt. Immunobiology. 2016 Jan;221(1):48-55. doi: 10.1016/j.imbio.2015.08.003. Epub 2015 Aug 17. Immunobiology. 2016. PMID: 26307002

6

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

Xie L, Jiang FC, Zhang LM, He WT, Liu JH, Li MQ, Zhang X, Xing S, Guo H, Zhou P. Xie L, et al. Among authors: he wt. J Natl Cancer Inst. 2015 Dec 28;108(4):djv364. doi: 10.1093/jnci/djv364. Print 2016 Apr. J Natl Cancer Inst. 2015. PMID: 26712311

7

Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.

He WT, Zhang LM, Li C, Li SY, Ding ZC, Fang ZM, Meng FY, Chen ZK, Zhou P. He WT, et al. Transpl Int. 2016 Aug;29(8):941-52. doi: 10.1111/tri.12789. Epub 2016 Jun 14. Transpl Int. 2016. PMID: 27125343 Free article.

8

Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.

Zhang LM, Liu JH, Xue CB, Li MQ, Xing S, Zhang X, He WT, Jiang FC, Lu X, Zhou P. Zhang LM, et al. Among authors: he wt. Sci Rep. 2016 Jun 1;6:26954. doi: 10.1038/srep26954. Sci Rep. 2016. PMID: 27246399 Free PMC article.

9

Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.

Zhang X, Xing S, Li M, Zhang L, Xie L, He W, Liu J, Chang S, Jiang F, Zhou P. Zhang X, et al. Metabolism. 2016 Sep;65(9):1267-77. doi: 10.1016/j.metabol.2016.05.005. Epub 2016 May 14. Metabolism. 2016. PMID: 27506734

10

Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.

Wang F, He W, Yuan J, Wu K, Zhou H, Zhang W, Chen ZK. Wang F, et al. Transpl Immunol. 2008 Apr;19(1):12-9. doi: 10.1016/j.trim.2008.01.008. Epub 2008 Feb 20. Transpl Immunol. 2008. PMID: 18346632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters